Business Context and Reporting Period
This Form 6-K filing was submitted by GlaxoSmithKline plc, GlaxoSmithKline Capital plc, and GlaxoSmithKline Capital Inc. on May 2, 2012. The report serves to incorporate a specific financial exhibit by reference into the registrants' Registration Statement on Form F-3 (File No. 333-172621).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document solely references the inclusion of a "Statement of Computation of Ratio of Earnings to Fixed Charges" as Exhibit 12.1, but does not display the numerical data within the text of this report.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. The document is procedural in nature, focusing on the incorporation of an exhibit into a registration statement.
Investor Verification Checklist
- Verify the specific numerical data within Exhibit 12.1 (Statement of Computation of Ratio of Earnings to Fixed Charges) referenced in this filing.
- Review the full Registration Statement on Form F-3 (File No. 333-172621) for comprehensive financial context.
- Confirm the status of the registrants' annual reporting obligations under Form 20-F.